Carlo Russo

Chief Tech/Sci/R&D Officer presso GENENTA SCIENCE S.P.A.

Patrimonio netto: 2 M $ in data 31/03/2024

71 anni

Health Technology

Consumer Services

Profilo

Carlo Russo is currently the Chief Medical Officer & Head-Development at Genenta Science SpA since 2021.
Prior to this, he was the President & CEO at VaxInnate Corp.
He also served as the Chief Medical Officer & Executive Vice President at Adverum Biotechnologies, Inc. in 2016.
Dr. Russo holds a doctorate degree from the University of Genoa.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
GENENTA SCIENCE SPA 3.28%	19/04/2023	598 417 ( 3.28% )	2 M $	31/03/2024

Posizioni attive di Carlo Russo

Società	Posizione	Inizio
GENENTA SCIENCE S.P.A.	Chief Tech/Sci/R&D Officer	01/01/2021

Tutte le posizioni attive di Carlo Russo

Precedenti posizioni note di Carlo Russo

Società	Posizione	Fine
ADVERUM BIOTECHNOLOGIES, INC.	Chief Tech/Sci/R&D Officer	01/07/2016
VaxInnate Corp. VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ.	Chief Executive Officer	-

Vedi nel dettaglio l'esperienza di Carlo Russo

Formazione di Carlo Russo

University of Genoa

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Carlo Russo

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ADVERUM BIOTECHNOLOGIES, INC.	Health Technology
GENENTA SCIENCE S.P.A.	Health Technology

Aziende private	1
VaxInnate Corp. VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ.	Health Technology